Related Experiment Video
Updated: Apr 27, 2026
06:57
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
10.5K
Concordance in cervical HPV detection between hybrid capture 2 and HPV GenoArray tests
Li Zhang1, Yong Lin, Jin-ke Li
1Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China
Asian Pacific Journal of Cancer Prevention : APJCP
|June 28, 2014
Summary
Type-specific human papillomavirus (HPV) detection shows good agreement between two tests. This supports using specific HPV testing for cervical cancer screening and vaccine development.
Area of Science:
- Oncology
- Virology
- Medical Diagnostics
Background:
- Cervical cancer is a significant global health concern, often linked to persistent HPV infections.
- Accurate HPV type-specific detection is crucial for effective cervical cancer screening and the development of targeted vaccination strategies.
Purpose of the Study:
- To compare the performance of the HPV Hybrid Capture II (HC II) Test and the Hybribio GenoArray test for HPV type-specific detection.
- To evaluate the concordance between these two HPV testing methods in patients with cervical epithelial neoplasm.
Main Methods:
- The study involved patients diagnosed with cervical epithelial neoplasm.
- HPV detection was performed using both the HPV Hybrid Capture II (HC II) Test and the Hybribio GenoArray test.
- Statistical analysis, including the McNemar test and kappa value calculation, was used to assess concordance.
Main Results:
- A high level of concordance was observed between the HPV Hybrid Capture II (HC II) Test and the Hybribio GenoArray test for cervical HPV detection.
- The kappa value for agreement was 0.80 (p<0.05), indicating statistically significant concordance.
Conclusions:
- The Hybribio GenoArray test demonstrates good concordance with the established HPV Hybrid Capture II (HC II) Test.
- Findings support the increased utilization of type-specific HPV detection assays in clinical practice.
- Type-specific HPV detection can enhance cervical cancer screening programs and inform vaccination strategies.
